Page last updated: 2024-10-28

idebenone and Parkinson Disease, Secondary

idebenone has been researched along with Parkinson Disease, Secondary in 1 studies

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research Excerpts

ExcerptRelevanceReference
"Idebenone is an analog of the well-known antioxidant compound coenzyme Q10 (CoQ10)."1.62Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation. ( Avcı, B; Bilge, SS; Günaydın, C; Güvenç, T; Kuruca, N; Yavuz, CK, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Avcı, B1
Günaydın, C1
Güvenç, T1
Yavuz, CK1
Kuruca, N1
Bilge, SS1

Other Studies

1 other study available for idebenone and Parkinson Disease, Secondary

ArticleYear
Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.
    Neurochemical research, 2021, Volume: 46, Issue:3

    Topics: Animals; Antioxidants; Brain; Dopaminergic Neurons; Lipid Peroxidation; Locomotion; Male; Neuroprote

2021